Support for Vaccine Development
Deadline: 15 May 2014 5:00 p.m. CET
Anticipated Decision Date 30 June 2014

Please forward this message to anyone who could be interested.

The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the development of novel and powerful immunization technologies for the next generation of human vaccines. ADITEC is coordinated by the Sclavo Vaccines Association (SVA): a non-profit organization that strives to ensure long-term sustainability of European vaccine R&D efforts.

ADITEC constitutes an important cornerstone of an expanded vaccine research partnership, geared to boost European research in the field of immunology and vaccinology. It is within this context that ADITEC will give interested vaccine R&D users free access to consortium "in house" available vaccinology expertise and technologies.

By facilitating better coordination among European organizations involved in vaccine research, ADITEC hopes to expand European industry capacity in terms of vaccine R&D and production, thus promoting competitiveness of European health industries and significantly impacting population health in the future.

Commissioned research support for European Small and Medium size Enterprises (SME) and Public Health Organizations.
The ADITEC project is looking to support SMEs and public health organizations from within or outside the ADITEC consortium in vaccine development work that will result in public health benefit. We are actively seeking research proposals clearly aimed at vaccine development, where specific support can be requested in the areas listed below.

These services are offered by current ADITEC consortium partners and are available free of charge to the requesting SME or public health organization, upon approval of the proposal. A total of 1.3 million Euros from ADITEC funding is available and up to 100 k€ of services may requested per project. The ADITEC project will reimburse the service-providing ADITEC partners directly for services provided. There will be no cost to the awarded SME or public health organization for the research services provided. Resulting IP will be owned by the SME or public health organization receiving the service, and maybe shared with the ADITEC partner(s) performing the research. It will be expected that results of the "commissioned research work" will be made available to European users, and the ADITEC support will be acknowledged. Successful external applicants, are expected to become an ADITEC "Affiliated Member" including all respective rights as described in the Affiliated Member Application found on this page the ADITEC website.

General Application Information
For questions regarding any aspect of the submission process, please contact the ADITEC Project Manager Lynn Zimmerman.

Eligible Organizations: European SMEs and Public Health Organizations

• The applicant performs the majority of its work in an institution established in a European Member State or Associated State
• Is an small or medium-sized enterprise (SME, an enterprise which employs fewer than 250 persons and has an annual turnover not exceeding 50 million euro, and/or an annual balance sheet total not exceeding 43 million euro. For additional information on the definition of an SME, please see the website of the European Commission
• Is a Public Health Organization.
• Able to commercialize or openly disseminate the results.